Following a procedure in Mar 2024 to address a significant BPH problem, I had a 3T mpMRI on 14 October. I saw the (private) consultant on the 18th and received a letter on 21 Oct. Key points:
Prostate size 40ml. PSA 4. PSA density 0.10ng/ml. I was advised in April that analysis of the tissue removed in the procedure detected Gleason 3+3, on a low volume of < 5%, but that it was essentially not a concern, and that an active surveillance type of approach was appropriate, which at the time seemed reasonable to me.
The consultant has of course advised that a biopsy will be required, with a target timeline of 'before Christmas'.. I used self-funding for the BPH procedure, on a one-off basis, but am certainly not comfortable with handling a cancer condition similarly.
My GP is aware and has contacted me re possible referral to NHS Urology (St Georges), but it will be about a week before the appointment with the GP.
My immediate concerns are the potential for breakout from the capsule, and (probability?) of the NHS being unable to meet the indicated timeline.
I would be very grateful for your comments. Having done a considerable amount of reading, I am familiar with Gleason scoring and other related terminology.
Hi Peroni
Just wondered why u started down the private route, wouldn't NHS sort out BPH?
You have had a biopsy a few months ago and now they wanting do another one?
They suggested active surveillance but now there is some concern it could be near the gland edge.
Perhaps I 'm reading it incorrectly but does seem a bit strange
Regards
Steve
Hi Steve. Thanks for the response.
Re the BPH, my preference was for a particular procedure (alternative to TURP), with a lower risk profile, which I was not able to access via the NHS in my area, or indeed in most areas.
The earlier Gleason 3+3 was not picked up via a biopsy (where tissue is extracted from the prostate on a targeted or systematic basis). It was picked up, on an incidental type of basis, from the tissue removed during the BPH procedure.
At that time (Apr.2024) the consultant recommended an MRI approx 6 months after the BPH procedure, to be followed by the normal (as I understand it) active surveillance schedule of subsequent MRIs at 12 months and PSAs at 3 or 6 months. Assuming of course that the first MRI was 'good', which unfortunately is certainly not the case.
So the upcoming biopsy will be my first. Cheers.
That's a fair comment. However given my age (69 - will add this to my profile), I understand that it's a statistical probability that I will have Gleason 3+3. So that may have provided (false) reassurance.
I also understand that these days biopsies are at least partially targeted, which would have necessitated doing an MRI first (my only other MRI was in 2017).
I do agree with your general drift that there could have been more thorough investigation / follow-up at an earlier point(s).
Don't think correct , most men over certain age have a 3+3 but obviously could be wrong.
Anyway thinking positively good luck with the upcoming biopsy, let's hope 3+3 or less..
One thing to confirm with them, is how near tumour to capsule edge , probably the most important point.
PSA near normal, so there's a good point
Best wishes
Steve
Hi Peroni and Grundo .
I'm not usually keen to quote the Daily Telegraph, but I foudn the article on this link interesting:
https://www.telegraph.co.uk/health-fitness/conditions/cancer/prostate-health-cancer-how-to-check/
It matches some figures that I have seen before, possibly on Cancer Research, but I have been unable to find them immediately.
Steve
(update Tue 05 Nov)
Saw my GP (who has been notably proactive and helpful) last Wed 30 Oct late afternoon. He booked an appt with the Urology Dept for Mon 04 Nov.
However on the following day (Thu 31) I received a call from a urology dept 'care path navigator', who very helpfully offered me an appt for 10am on the following day (Fri 01 Nov) instead, subject to the detailed MRI images generated by the private clinic, and the associated detailed report, being acquired in sufficient time for the urologist to study them prior to the appt.
It was a bit of a scramble to get the images in time, but apparently there is a back-office system whereby the NHS can acquire the images directly from registered health entities, and upload them to their system for review. Anyway, it got done in time.
So on Fri 01 Nov I had a very useful meeting with the consultant - impressive credentials, and excellent 'bedside manner', which always really helps. Key points:
- Probability of cancer 90%. (guessing this means cancer exceeding the AS threshold). Not a surprise to me.
- Stage currently seen as T3a (tumour has spread through the capsule surrounding the prostate)
- Primary treatment seen as surgery, possibly with radiotherapy as a supplement (just touched on, no discussion).
- Treatments such as brachytherapy seen as unlikely to be suitable.
- Biopsy transperineal under local anaesthetic
- Biopsy is 'fusion guided'. i.e. real-time ultrasound images merged with stored MRI images.
- Full set of targeted and systematic cores. I forget the number, maybe 12.
- Said that the subcapsular nature of the lesions did not adversely impact the ability to take accurate cores.
- Next step is a biopsy, now scheduled for Fri 08 Nov
- Results appt expected Wed 20 Nov.
- PET scan may follow.
Whatever cancer throws your way, we’re right there with you.
We’re here to provide physical, financial and emotional support.
© Macmillan Cancer Support 2024 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 3rd Floor, Bronze Building, The Forge, 105 Sumner Street, London, SE1 9HZ. VAT no: 668265007